<DOC>
	<DOCNO>NCT00508417</DOCNO>
	<brief_summary>This study , conduct Malaria Research Training Center Faculty Medicine Bamako NIAID measure frequency occurrence malaria infant Bancoumana , Mali . Information study help planning trial malaria vaccine . Healthy child 6 week 6 month age live Bancoumana health area may eligible study . Candidates screen physical examination blood test . Participating child visit home total 17 visit see well . They come clinic every month 7-month study clinical evaluation , include blood sample obtain finger prick test malaria . Some blood collect may store use research . Children become sick malaria treat disease .</brief_summary>
	<brief_title>Malaria Incidence Infants Bancoumana , Mali</brief_title>
	<detailed_description>This observational study determine burden malaria rural Malian infant . Infants identify village-wide census Expanded Program Immunization ( EPI ) visit . After obtain community consent , eligible infant ' parent invite bring infant clinic screening . Enrolled infant receive baseline evaluation monthly visit rainy season time receive interim evaluation heel , toe , finger prick determination hemoglobin , thick thin blood film , malaria antibody titer ( first last visit transmission season ) , hemoglobin type one visit . Study subject also receive weekly home visit determine well ill . If ill febrile visit , present clinic unscheduled visit , subject receive history physical examination , heel , toe , finger prick determination hemoglobin , thick thin blood film , filter paper blood collection RDT malaria . Diagnosis treatment malaria perform accord Mali National Malaria Control Program ( NMCP ) guideline . Diagnosis treatment condition perform determined treat clinician .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<criteria>INCLUSION CRITERIA : 1 . Infants least six week less 7 month age enrollment 2 . Known resident Bancoumana health area 3 . Good general health determine clinical exam 4 . Available 67 month duration trial 5 . Willingness participate evidence signing informed consent fingerprint parent guardian EXCLUSION CRITERIA : 1 . Social , behavioral , cognitive , psychiatric condition opinion investigator affect ability volunteer parent/legal guardian understand cooperate study protocol 2 . Participation investigational vaccine drug trial within 30 day start study , study ongoing 3 . Infant born mother know suspected HIV/AIDS determine clinician</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>February 11, 2011</verification_date>
	<keyword>Malaria Incidence</keyword>
	<keyword>Anemia</keyword>
	<keyword>Clinical Malaria</keyword>
</DOC>